Savvy Update 11/27/23: DFMO May Preserve B-Cell Function, Drs. Steve & Jeremy Wisdom, Food for Thought: HUMOR
Already-Available Drug Could Help Treat Type 1 Diabetes by Miriam Tucker for Medscape.com, 20 November 2023. The drug α-difluoromethylornithine (DFMO) may help preserve beta-cell function in people with new-onset type 1 diabetes, new preliminary data...
Savvy Updates 11/13/23: Diamyd Medical/DiaUnion Trial for Precision Medicine, Cost of Diabetes Skyrockets, OptumRx Moves Insulin to Preferred Status, FDA Warns Against SugarMD Supplement, Human Insulin Storage, Interview with Dr. Mike Natter, Broccoli Benefits, Food for Thought with Gina Pillini
Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial posted on PRNewsWire.com, 7 November 2023. Diamyd Medical has entered into a collaboration agreement with DiaUnion, a center of excellence in type 1 diabetes, to...
Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App
Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System in a press release on NewsWire.com, 4 January 2023. Caution: The iLet Bionic Pancreas is an investigational device...
Savvy Updates, 1/2/23: Ozempic Shortages, Artificially Sweetened Drinks & Incontinence, Worldwide Surge in Diabetes, FDA Regulating Practice of Medicine, Happy New Year
Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages by Nicole DeFeudis for EndPoints.com, 13 December 2022. On the heels of Wegovy supply troubles, Novo Nordisk is reporting a shortage of its diabetes treatment Ozempic which contains...
Savvy Updates, 12/5/22: Ypsomed MyLife Loop, Insulin Resistance & CVD & Depression, HearO App Predicts Heart Failure, Biscuits, Low Carb Grilled Feta, Cows Wearing Trackers
Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3 was reported by Sean Whooley for DrugDeliveryBusiness.com, 28 November 2022. Ypsomed announced that its mylife Loop now has authorization to work with the Abbott...
More Diabetes Blogs